Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety

World Journal of Biological Psychiatry

Volumn 13, Issue 7, 2012, Pages 535-543

  Molendijk, Marc L ^a   Bus, Boudewijn A A ^b   Spinhoven, Philip ^a,c   Penninx, Brenda W J H ^c,d,e   Prickaerts, Jos ^f   Oude Voshaar, Richard C ^e   Elzinga, Bernet M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Anxiety; BDNF; Depression; Gender; Neurotrophin hypothesis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY DISORDERS; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; YOUNG ADULT;

EID: 84866297881     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.587892     Document Type: Article

References (51)

1. Almeida OP, Lautenschlager N, Vasikaram S, Leedman P, Flicker L. 2005. Association between physiological serum concentration of estrogen and the mental health of community dwelling postmenopausal women age 70 years and over. Am J Ger Psychiatry 13:142-149. (Pubitemid 41031103)
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association.
3. Beck AT, Epstein N, Brown G, Steer RA. 1988. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893-897. (Pubitemid 19008360)
4. Begliuomini S, Casarosa E, Pluchino N, Lenzi E, Centofanti M, Freschi L, et al. 2007. Influence of endogenous and exogenous sex hormones on plasma brain-Derived neurotrophic factor. Hum Reprod 22:995-1002.
5. Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99-125. (Pubitemid 41242884)
6. Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg JB, Pagano M, et al. 2005. Influence of psychiatric comorbidity on recovery and recurrence in generalizedanxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162:1179-1187. (Pubitemid 40770702)
7. Bus BAA, Molendijk ML, Penninx BJWH, Buitelaar JK, Kenis G, Prickaerts J, et al. 2011. DEterminants of serum brain-Derived neurotrophic factor. Psychoneuroendocrinology 36:228-239.
8. Cohen J. 1988. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
9. Chen Z-Y, Jing D, Bath KG, Ieraci A, Khan T, Siao C-J, et al. 2006. Genetic variant BDNF (val 66 met) polymorphism alters anxiety-related behavior. Science 314:140-143. (Pubitemid 44547760)
10. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. 2003. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381-1395. (Pubitemid 36936159)
11. David DJ, Samuels BA, Rainer Q, Wang J-W, Marsteller D, Mendez I, et al. 2009. Neurogenesis-dependent and-independent effects of fluoxetine in an animal model of anxiety/Depression. Neuron 62:479-493.
12. Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127.
13. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of Depression. Arch Gen Psychiatry 54:597-606. (Pubitemid 27306570)
14. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, PanDEy GN. 2003. Altered gene expression of brain-Derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide victims. Arch Gen Psychiatry 60: 804-815. (Pubitemid 36960912)
15. Gass P, Hellweg R. 2010. Peripheral brain-Derived neurotrophic factor (BDNF) levels as a biomarker for affective disorders. Int J Neuropsychopharmacol 13:1-4.
16. Govindarajan A, Rao BSS, Nair D, Trinh M, Mawjee N, Tonegawa S, et al. 2006. Transgenic brain-Derived neurotrophic expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103:13208-13213. (Pubitemid 44338941)
17. Green MJ, Matheson SL, Sheperd A, Weickert CS, Carr VJ. 2010. Brain-Derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry (advance online publication, 24 August 2010; 10.1038/mp.2010.88).
18. Groves JO. 2008. Is it time to reassess the BDNF hypothesis of Depression? Mol Psychiatry 12:1079-1088.
19. Huang TL, Lee CT, Liu YL. 2008. Serum brain-Derived neurotrophic factor levels in patients with major Depression: effects of antidepressants. J Psychiatr Res 42:521-525.
20. Kabacoff RI, Segal DL, Hersen M, van Hasselt VB. 1997. Psychometric properties and diagnostic utility of the Beck anxiety inventory and the state-trait anxiety inventory with older adult psychiatric outpatients. J Anxiety Disord 11:33-47. (Pubitemid 27199171)
21. Kapczinski F, Dal-Pizzol F, Teixera AL, Magalhaes PVS, Kauer-Sant'Anna M, Klamt F, et al. 2010. A systematic toxicity index developed to assess peripheral changes in mood Episodes. Mol Psychiatry 15:784-786.
22. Karege F, Perret G, BondolfiG, Schwald M, Bertschy G, Aubry JM. 2002a. Decreased serum brain-Derived neurotrophic factor in major depressed patients. Psychiatry Res 109:143-148. (Pubitemid 34258493)
23. Karege F, Schwald M, Cisse M. 2002b. Postnatal Developmental profile of brain-Derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261-264. (Pubitemid 34876661)
24. Karege F, BondolfiG, Gervasoni N, Schwald M, Aubrey J-M, Bertschy G. 2005. Low brain-Derived neurotrophic factor (BDNF) levels in serum probably result from lowered platelet BDNF release unrelated to BDNF reactivity. Biol Psychiatry 57:1068-1072. (Pubitemid 40613035)
25. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1992. Major Depressive disorder and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49:716-722.
26. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. 1995. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women: phobia, generalized anxiety disorder, panic disorder, bulimia, major Depression, and alcoholism. Arch Gen Psychiatry 52:374-383.
27. Klaassen T, Klumperbeek J, Deutz NE, van Praag HM, Griez E. 1998. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge. Psychiatr Res 77:167-174. (Pubitemid 28157268)
28. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. 2010. Blood BDNF concentrations reflect braintissue BDNF levels across species. Int J Neuropsychopharmacol 14:347-353.
29. Kobayashi K, Shimuzu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, et al. 2005. Serum Brain-Derived Neurotrophic Factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 29:658-663. (Pubitemid 40897773)
30. Krishnan V, Nestler EJ. 2010. Linking molecules to mood: new insight into the biology of Depression. Am J Psychiatry 167:1305-1320.
31. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Lowe B. 2007. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and Detection. Ann Int Med 146:317-325. (Pubitemid 351650592)
32. Kulkarni J, DE Castella A, Fitzgerald PB, Gurvich CT, Bailey M, Burger H. 2008. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65:955-960.
33. Lyketos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW. 1994. The life chart interview: a standardized method to DEscribe the course of psychopathology. Int J Methods Psychiatr Res 4:143-155.
34. Maron E, Toru I, Vasar V, Shlik J. 2004. The effect of 5-hydroxy trypthophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol 18:194-199. (Pubitemid 38954906)
35. Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in Depression and anxiety. Nat Neurosci 10:1089-1093. (Pubitemid 47339961)
36. Molendijk ML, Bus BAA, Spinhoven Ph, Penninx, BJWH, Kenis G, Prickaerts, et al. 2010. Serum levels of brain-Derived neurotrophic factor in major Depressive disorder: state and trait issues, clinical features, and pharmacological treatment. Mol Psychiatry (e-pub ahead of print 21 September 2010; doi: 10.1038/mp201098).
37. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, et al. 2007. Brain-Derived neurotrophic factor conditional knockouts show gender differences in Depression-related behaviors. Biol Psychiatry 61:187-197. (Pubitemid 46072778)
38. Nakazato M, Hashimoto K, Shimuzu E, Kumakiri C, Koizumi H, Okamura N, et al. 2003. Decreased levels of serum brainDerived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 54:485-490. (Pubitemid 37289455)
39. Penninx BJW, Beekman ATH, Smit JH, Zitman FG, Nolen WA, Spinhoven Ph, et al. for the NESDA Research Consortium. 2008. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 17:121-140.
40. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. 1996. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26:477-486. (Pubitemid 26142491)
41. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, et al. 2009. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42:270-276.
42. Scharfman HE, MacLusky NJ. 2004. Similarities between actions of estrogen and BDNF in the hippocampus: coincidence or clue? Trends Neursci 28:79-85. (Pubitemid 40178924)
43. Seeman MV. 1997. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154:1641-1647. (Pubitemid 27516578)
44. Sen S, Duman R, Sanacora G 2008. Serum brain-Derived neurotrophic factor, Depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64: 527-532.
45. Strohle A, Stoy M, Graetz B, Scheel M, Wittman A, Galinat J, et al. 2010. Acute exercise ameliorates reduced brain-Derived neurotrophic factor in patients with panic disorder. PNEC 35:364-368.
46. Wacker HR, Battegay R, Mullejans R, Schlosser C (2006). Using the CIDI-C in the general population. In: Stefanis CN, Rabavilas AD, Soldatos CR, editors. Psychiatry: a world perspective. Amsterdam, The Netherlands: Elsevier Science Publishers.
47. Walf AA, Frye CA. 2006. A review and update of mechanisms of estrogen in the hippocampus and amygdale for anxiety and Depression behavior. Neuropsychopharmacology 31: 1097-1111. (Pubitemid 43971828)
48. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. 1991. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The multicentre WHO/ADAMHA field trials. Br J Psychiatry 159:645-653.
49. World Health Organization (WHO). 2010. Collaborating centre for drug statistics methodology. Anatomical Therapeutic Chemical (ATC) Classification http://www.whocc.no/atcddd; accessed April 2010.
50. Young E, Korszun A. 2010. Sex trauma, stress hormones and Depression. MolPsychiatry 15:23-28.
51. Ziegenhorn A, Schulte-Herbruggen O, Danker-Hopfe M, Malbranc H, Hartung D, Anders U, et al. 2007. Serum neurotrophins-a study on the time course and influencing dactors in a large old age sample. Neurobiol Aging 28:1436-1445. (Pubitemid 47090171)